Aggrastat Injection, Solution
Product Images NDC 25208-902

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Aggrastat (NDC 25208-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medicure International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15ml-label (15ml Label)

Label for Aggrastat (tirofiban hydrochloride) Injection, 3.75 mg per 15 mL (250 mcg/mL), 15 mL single-dose vial. For intravenous use only, produced by Medicure Pharma, Inc. The label includes storage instructions to protect from light and discard unused portion. Marked Rx only with NDC 25208-901-04.*

FDA Label Image

Small-carton (3 75 mg Carton)

Packaging label for AGGRASTAT (tirofiban hydrochloride) Injection 3.75 mg per 15 mL (250 mcg/mL) in a 15 mL single-dose vial. Label includes administration instructions for intravenous use, formulation details, storage conditions, and manufacturer information from Medicure International Inc. The label also notes protection from light during storage and discarding unused portion.*

FDA Label Image

Figure1 (Aggrastat Figure1)

A line graph titled 'Composite Endpoint 180-Day Follow-Up' comparing the proportion with endpoint over time (study days 0 to 180) between Heparin alone and AGGRASTAT plus Heparin. The graph shows risk reduction percentages of 22% (p=0.029) and 19% (p=0.024) for AGGRASTAT plus Heparin at different study periods.*

FDA Label Image

Structure (Aggrastat Struct Formula)

Chemical structure of Tirofiban, the active ingredient in AGGRASTAT injection. The structure includes a piperidine ring linked by an ether chain to a substituted phenyl group with sulfonamide, carboxyl, hydrochloride, and water components.*

FDA Label Image

Equation-1 (Equation 1)

A formula for calculating the bolus volume in milliliters (mL) of a drug solution. It shows the ratio of 25 mcg per kilogram of body weight (kg) divided by the concentration of 250 mcg per milliliter (mL). This equation is likely used for dosing AGGRASTAT (tirofiban) intravenous injection based on patient weight.*

FDA Label Image

Equation-2 (Equation 2)

A mathematical formula for calculating bolus volume in milliliters based on body weight and concentration. The formula expresses bolus volume as 25 micrograms per kilogram multiplied by body weight in kilograms, divided by a concentration of 50 micrograms per milliliter.*

FDA Label Image

Equation-3 (Equation 3)

A mathematical formula displaying the infusion rate calculation for AGGRASTAT (tirofiban) intravenous injection based on creatinine clearance greater than 60 mL/min. The formula incorporates dosage, body weight in kilograms, and infusion duration to determine mL per hour infusion rate.*

FDA Label Image

Equation-4 (Equation 4)

A formula calculating infusion rate for AGGRASTAT (Tirofiban) based on creatinine clearance above 60 mL/min. It shows dosage per body weight per time divided by drug concentration to determine milliliters per hour for intravenous administration.*

FDA Label Image

Equation-5 (Equation 5)

Mathematical formula illustrating the infusion rate calculation for a drug, based on creatinine clearance (CrCl) less than or equal to 60 mL/min. The formula includes variables for micrograms per kilogram per minute, body weight in kilograms, time in minutes per hour, and concentration in micrograms per milliliter.*

FDA Label Image

Carton5mg-100ml-bag (Pack 1 100ml)

AGGRASTAT (tirofiban hydrochloride) Injection 5 mg per 100 mL (50 mcg per mL) solution in a 100 mL single-dose container. The label includes usage instructions and storage information. Manufactured for Medicure International Inc, with distribution by Medicure Pharma Inc. The label features the Novaplus logo and contains standard barcode and lot information areas.*

FDA Label Image

Insert (Pack 1 250ml)

Label for AGGRASTAT (tirofiban hydrochloride) injection, 12.5 mg per 250 mL solution in a 250 mL single-dose container. The label includes usage instructions, storage conditions, and manufacturer information for Medicure International Inc. It is recommended for use with calibrated infusion devices and is sterile and iso-osmotic.*

FDA Label Image

Pouch-5-mg-100-ml-bag (Pack 2 100ml)

AGGRASTAT (tirofiban hydrochloride) Injection 5 mg per 100 mL is an intravenous injection solution in a 100 mL single-dose container. The label includes storage instructions, formulation details, and manufacturer information showing Medicure International, Inc. and Laboratorios Grifols S.A. This product is for prescription use only.*

FDA Label Image

Container (Pack 2 250ml)

AGGRASTAT (tirofiban hydrochloride) Injection label for a 250 mL single-dose container. The label shows a strength of 12.5 mg per 250 mL (50 mcg per mL). The label includes storage and usage instructions, manufacturer and distributor information for Medicure International Inc. and Medicure Pharma, Inc., and cautions related to the solution's clarity and usage.*

FDA Label Image

Label-5-mg-100-ml-bag (Pack 3 100ml)

Label for AGGRASTAT (Tirofiban Hydrochloride) Injection, 5 mg per 100 mL intravenous solution in a 100 mL single-dose container. The label includes dosing and storage instructions, manufacturer Medicure Pharma, Inc., and barcode with QR code. The product is sterile, nonpyrogenic, and premixed for use with a calibrated infusion device.*

FDA Label Image

Carton 12.5/250ml – Bag (Pack 3 250ml)

AGGRASTAT (tirofiban hydrochloride) Injection 12.5 mg per 250 mL (50 mcg per mL) solution for intravenous use in a 250 mL single-dose container. The label includes dosage strength, volume, storage instructions, manufacturer Medicure International Inc, and distributor information. The packaging also highlights protection from light and storage temperature guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.